Twinbeech Capital LP Arrowhead Pharmaceuticals, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $376,677 - $518,722	14,377 New	14,377 $386,000
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $3.88 Million - $6.31 Million	163,764 New	163,764 $4.16 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $313,992 - $963,968	-15,272 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $429,754 - $1.12 Million	15,272 New	15,272 $969,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.